Nephron Pharmaceuticals Corporation, a South Carolina-based company that develops and produces safe, affordable generic inhalation solutions and suspension products, announced on Thursday that it has named Julie Rameas as its new chief procurement officer.
In the new role, Rameas will manage all strategic sourcing and procurement activities.
Rameas has experience in pharmaceutical, medical device, metal, electronic, aerospace, automotive, and textile manufacturing industries. She has held the position of senior director of Global Strategic Procurement at Thermo Fisher Scientific and served in global director roles at Lear Corporation. She has also worked at BioMerieux, where she led spending on all chemicals, biologics and controlled substances.
Medtronic announces new, long-term data from SPYRAL HTN-ON MED clinical trial
Senzime unveils next-gen TetraGraph TOF monitor at ANESTHESIOLOGY 2024; US shipments to begin in Q4
Abbott launches new clinical trial to improve results in patients with advanced heart failure
United Therapeutics reaches milestone with 500th lung transplant via ex vivo lung perfusion service
Adocia patents stable hormone combinations for obesity and diabetes
GE HealthCare expands AI-enabled enterprise imaging with Blackford integration
Viatris reports positive results for EFFEXOR in GAD treatment in Japan
ALK secures U.S. FDA approval for AccuTest Allergy Skin Testing Devices
Brain+ launches Ayla CST Assistant following UK regulatory approval
Accelerate Diagnostics receives FDA clearance for automated blood culture system
Photocure's partner Asieris presents Cevira Phase III subgroup analysis at 2024 CSCO Annual Meeting
Boston Scientific's FARAPULSE Pulsed Field Ablation system receives Japanese regulatory approval